International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Special Issue 6
Original Research Article
Evaluating the Diagnostic Efficacy of Diffusion Weighted Imaging and MR Spectroscopy in Brain Tumor Classification
Published
Dec. 30, 2024
Abstract

Introduction: The objective is to evaluate efficacy of DWI and MR spectroscopy with conventional MRI in differentiation and grading of brain tumors. Material and Methods: A total number of 60 patients with brain tumours who were referred to Department of Radiodiagnosis, SSIMS&RC, Davanagere over a period of 2 years. Results: Study group consists of 39 male and 21 female patients, majority of the age group is 40.0%. Accordingly, the mean ADC value was 0.81 with a standard deviation of around ±0.216. However, the proportion of each diagnosis was found to be quite different from the actual diagnosis based on HPE, thereby suggesting the possibility of false reports from the DWI procedure. MRS was performed and ratios between choline and creatinine, NAA and creatinine, and choline and NAA to diagnose the condition. Conclusion: On performing both DWI and MRS among patients with history of headache and focal neurological deficits, the study observed the following; DWI was in correlation with ADC values which helped in diagnosing the condition appropriately in most of the cases. MR spectroscopy was successful in imaging and grading the brain tumors using the ratios between choline and creatinine, N-acetyl aspartate and creatinine, and choline and N-acetyl aspartate. MR spectroscopy proven to be more sensitive than diffusion weighted imaging in all the cases.

Recommended Articles
Loading Image...
Volume-5, Special Issue 6
Citations
728 Views
333 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved